Literature DB >> 16251410

Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes.

Traci A Wilgus1, Annette M Matthies, Katherine A Radek, Julia V Dovi, Aime L Burns, Ravi Shankar, Luisa A DiPietro.   

Abstract

Vascular endothelial growth factor (VEGF-A), a potent stimulus for angiogenesis, is up-regulated in the skin after wounding. Although studies have shown that VEGF is important for wound repair, it is unclear whether this is based solely on its ability to promote angiogenesis or if VEGF can also promote healing by acting directly on non-endothelial cell types. By immunohistochemistry and reverse transcriptase-polymerase chain reaction, expression of VEGF receptor-1 (VEGFR-1), but not VEGFR-2, was detected in murine keratinocytes during wound repair and in normal human epidermal keratinocytes (NHEKs). The presence of VEGF receptors on NHEKs was verified by binding studies with 125I-VEGF. In vitro, VEGF stimulated the proliferation of NHEKs, an effect that could be blocked by treatment with neutralizing VEGFR-1 antibodies. A role for VEGFR-1 in keratinocytes was also shown in vivo because treatment of excisional wounds with neutralizing VEGFR-1 antibodies delayed re-epithelialization. Treatment with anti-VEGFR-1 antibodies also reduced the number of proliferating keratinocytes at the leading edge of the wound, suggesting that VEGF sends a proliferative signal to these cells. Together, these data describe a novel role for VEGFR-1 in keratinocytes and suggest that VEGF may play several roles in cutaneous wound repair.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251410      PMCID: PMC1603795          DOI: 10.1016/S0002-9440(10)61213-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

1.  Loss of vascular endothelial growth factor in human alopecia hair follicles.

Authors:  C K Goldman; J C Tsai; L Soroceanu; G Y Gillespie
Journal:  J Invest Dermatol       Date:  1995-05       Impact factor: 8.551

2.  Vascular endothelial growth factor is a secreted angiogenic mitogen.

Authors:  D W Leung; G Cachianes; W J Kuang; D V Goeddel; N Ferrara
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

3.  Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

Authors:  C A Boocock; D S Charnock-Jones; A M Sharkey; J McLaren; P J Barker; K A Wright; P R Twentyman; S K Smith
Journal:  J Natl Cancer Inst       Date:  1995-04-05       Impact factor: 13.506

4.  Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells.

Authors:  M Detmar; K T Yeo; J A Nagy; L Van de Water; L F Brown; B Berse; B M Elicker; S Ledbetter; H F Dvorak
Journal:  J Invest Dermatol       Date:  1995-07       Impact factor: 8.551

5.  Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing.

Authors:  S Frank; G Hübner; G Breier; M T Longaker; D G Greenhalgh; S Werner
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

6.  Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth.

Authors:  K G Peters; C De Vries; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

7.  Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis.

Authors:  Johannes Jacobi; Betty Y Y Tam; Uma Sundram; Georges von Degenfeld; Helen M Blau; Calvin J Kuo; John P Cooke
Journal:  Gene Ther       Date:  2004-02       Impact factor: 5.250

8.  Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme.

Authors:  L F Brown; T J Harrist; K T Yeo; M Ståhle-Bäckdahl; R W Jackman; B Berse; K Tognazzi; H F Dvorak; M Detmar
Journal:  J Invest Dermatol       Date:  1995-05       Impact factor: 8.551

9.  Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.

Authors:  M Detmar; L F Brown; K P Claffey; K T Yeo; O Kocher; R W Jackman; B Berse; H F Dvorak
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

10.  Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.

Authors:  L F Brown; K T Yeo; B Berse; T K Yeo; D R Senger; H F Dvorak; L van de Water
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  44 in total

Review 1.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

Review 2.  A clinical-pathogenetic approach on associated anomalies and chromosomal defects supports novel candidate critical regions and genes for gastroschisis.

Authors:  Victor M Salinas-Torres; Rafael A Salinas-Torres; Ricardo M Cerda-Flores; Hugo L Gallardo-Blanco; Laura E Martínez-de-Villarreal
Journal:  Pediatr Surg Int       Date:  2018-08-09       Impact factor: 1.827

3.  Cutaneous manipulation of vascular growth factors leads to alterations in immunocytes, blood vessels and nerves: Evidence for a cutaneous neurovascular unit.

Authors:  Nicole L Ward; Denise A Hatala; Julie A Wolfram; Dorothy A Knutsen; Candace M Loyd
Journal:  J Dermatol Sci       Date:  2010-11-13       Impact factor: 4.563

Review 4.  The Roles of Growth Factors in Keratinocyte Migration.

Authors:  Mark A Seeger; Amy S Paller
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-04-01       Impact factor: 4.730

5.  Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis.

Authors:  Hyun Sil Lee; Allen Myers; Jean Kim
Journal:  Am J Respir Crit Care Med       Date:  2009-09-17       Impact factor: 21.405

6.  Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice.

Authors:  Carsten Deppermann; Deya Cherpokova; Paquita Nurden; Jan-Niklas Schulz; Ina Thielmann; Peter Kraft; Timo Vögtle; Christoph Kleinschnitz; Sebastian Dütting; Georg Krohne; Sabine A Eming; Alan T Nurden; Beate Eckes; Guido Stoll; David Stegner; Bernhard Nieswandt
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

7.  Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation.

Authors:  Brad A Bryan; Tony E Walshe; Dianne C Mitchell; Josh S Havumaki; Magali Saint-Geniez; Arindel S Maharaj; Angel E Maldonado; Patricia A D'Amore
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

8.  Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor.

Authors:  Cornelia Halin; Hermann Fahrngruber; Josef G Meingassner; Guido Bold; Amanda Littlewood-Evans; Anton Stuetz; Michael Detmar
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

9.  Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis.

Authors:  Themis R Kyriakides; Drausin Wulsin; Eleni A Skokos; Philip Fleckman; Annalisa Pirrone; J Michael Shipley; Robert M Senior; Paul Bornstein
Journal:  Matrix Biol       Date:  2009-01-20       Impact factor: 11.583

10.  A Live-Cell Screen for Altered Erk Dynamics Reveals Principles of Proliferative Control.

Authors:  Alexander G Goglia; Maxwell Z Wilson; Siddhartha G Jena; Jillian Silbert; Lena P Basta; Danelle Devenport; Jared E Toettcher
Journal:  Cell Syst       Date:  2020-03-18       Impact factor: 10.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.